Navigation Links
Tosedostat OPAL Study Final Results Selected for Oral Presentation at the 2011 American Society of Hematology (ASH) Annual Meeting
Date:12/6/2011

SEATTLE, Dec. 7, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced that final results from a study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia ("AML") was selected as on oral presentation at the 2011 American Society of Hematology ("ASH") Annual Meeting, which will be held on December 10-13, 2011, in San Diego, California.

Jorge Cortes, M.D., of The University of Texas MD Anderson Cancer Center, an investigator on the tosedostat study, is scheduled to present the data on Monday, December 12, 2011, during the "Acute Myeloid Leukemia - Therapy, excluding Transplantation: Clinical Studies" session that will be held from 4:30 p.m. to 6:00 p.m. Pacific time. The presentation, abstract #767, is titled, "Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia."

Additionally, results from CTI's PIX203 phase II study, in which pixantrone was substituted for doxorubicin in the CPOP-R regimen compared to the standard CHOP-R regimen in front-line aggressive non-Hodgkin's lymphoma was selected for a poster presentation.  The poster is scheduled to be presented in the "Lymphoma – Chemotherapy, excluding Pre-Clinical Models: Poster I" session on Saturday, December 10, 2011 that will be held from 5:30 to 7:30 p.m. Pacific time. The poster, abstract #1605, is titled "CPOP-R Versus CHOP-R as First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-Label, Multicenter Study."  

The study abstracts are available at www.hematology.org.

Investor and Analyst Meeting

Separately, CTI will host an investor and analyst meeting to present and discuss unmet medical needs in aggressive non-Hodgkin's lymphoma ("NHL"), AML and myelodysplastic s
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim®
2. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
3. New Study Shows AFECTAIR® Significantly Improved Delivery of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions
4. First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease
5. New Gene Study of ADHD Points to Defects in Brain Signaling Pathways
6. RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
7. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
8. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
9. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
10. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
11. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
(Date:9/30/2014)... PAUL, Minn. , Sept. 30, 2014 ... the United States abused prescription pain relievers ... include detoxification or maintenance treatment, which entails the use ... costs of these treatments are important when developing and ... by pharmacy benefit manager Prime Therapeutics LLC ...
(Date:9/30/2014)... , Sept. 30, 2014 Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... Model has been selected as a finalist in the ... Most Innovative New Product Awards, sponsored by CONNECT. CONNECT, ... innovative technology and life sciences products in ...
Breaking Medicine Technology:Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... Patient Advocacy Partners Forge Collaboration to Fund Discovery of New Drugs that ... and MILAN, Italy , Jan. 19 Fast ... National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF) ... type 1 diabetes in the world today announced a collaborative partnership with ...
... , VENLO, The Netherlands , Jan. 18 Results ... Lancet Oncology found that testing for high-risk types of the ... cancer than cytology (Pap testing) alone. The trial used QIAGEN,s digene® ... DNA Test), which detects the high-risk types of HPV that can cause ...
Cached Medicine Technology:Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes 2Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes 3Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes 4Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes 5Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 2Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 3Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 4Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 5Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 6
(Date:9/30/2014)... West Palm Beach, Florida (PRWEB) September 30, 2014 ... of Florida make the treatment of gum disease ... traditional treatments of the past. , “If you’ve ever felt ... into ice cream or sip a cold beverage, it’s possible ... Herbert Salisbury , who is a general dentist in ...
(Date:9/30/2014)... U.S. Department of Defense has made progress in reducing ... such as depression and post-traumatic stress disorder, but more ... Corporation study. , Despite efforts of both the Defense ... health services, many service members still do not seek ... have made a concerted effort to promote treatment as ...
(Date:9/30/2014)... FL (PRWEB) September 30, 2014 ... calcium hydroxylapatite, Poly-L-lactic acid) are used in several ... fat loss in patients, but are primarily used ... as skin rejuvenation—in particular, these fillers are being ... such as restoring smoother skin in the hands. ...
(Date:9/30/2014)... 30, 2014 To mark National Sickle ... of Living with a Disability magazine has ... hematological disorders as disabling conditions. , As ... a diagnosis to establish a disability related to a ... hereditary telangiectasia, coagulation defects, polycythemia vera, and aplastic anemias ...
(Date:9/30/2014)... 2014 Coast Dental and Orthodontics ... its newest practice, located at 1010 Shaw Avenue in ... general dentistry services , and specialty dental care including ... providing affordable and convenient dental care, our Clovis dentists ... . Call Coast Dental at 559-777-6113 to schedule an ...
Breaking Medicine News(10 mins):Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 3Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 4Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3
... April 21 Autism Support Network ( ... Foundation, Inc. ( http://www.aacfinc.org ) ... help reduce the financial burden experienced by families coping ... necessary assistance for their autistic loved ones. As part ...
... , ... Morrisville, NC (PRWEB) April 21, 2009 -- ... Carolina,s Triangle region, has launched the RadarFind Real Time Location ... as a development partner since April 2008, the hospital is sharing ...
... help pharmaceutical companies find, evaluate and manage drug ... the drug development lifecycleSAN FRANCISCO, April 21 ... development partnering site for the pharmaceutical development and ... and website, goBalto.com. goBalto transforms the way drug-development ...
... study indicating that 98% of breast cancer patients are satisfied with ... , Dr. Bob Basu explains why breast reconstruction following a mastectomy ... ... Houston TX (Vocus) April 21, 2009 -- The American Society of ...
... a new medical billing company, announces services that help medical professionals ... changes to the healthcare industry. , ... (PRWEB) April ... has called upon the nation,s healthcare system to step up efforts ...
... health databank promise to speed scientific discovery.MILWAUKEE, April ... announces the launch of its ... ORBIT . This dynamic research instrument may ... widely diverse library of specimens to be used ...
Cached Medicine News:Health News:Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism 2Health News:Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism 3Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 2Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 3Health News:WakeMed Shares Best Practices for Tracking Assets, Patients 4Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 2Health News:Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com 3Health News:Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy 2Health News:Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy 3Health News:Dr. America Comes to Obama's Aid, Helps Doctors Digitize 2Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 2Health News:Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument 3
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: